COSAN (CSAN3) Main Indicators
Basic Data - CSAN3
| Company | COSAN |
| Corporate Name | COSAN S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Produção de Açúcar. Etanol e Cogeração de Energia. Distribuição de Combustíveis.Produção e Distribuição de Lubrificantes.Tranporte e Carregamento de Açúcar. Operador de Terras e Distribuição de Gás. |
| Share | CSAN3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 11.00 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 117.82 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Petróleo. Gás e Biocombustíveis |
| Subsector | Petróleo. Gás e Biocombustíveis |
| Segment | Exploração. Refino e Distribuição |
| Participation Indexes | AGFS, IBOVESPA, IBRA, IBRX, IBRX50, ICO2, IGC, IGCT, IGNM, ISE, ITAG, IVBX, MLCX |
| Updated 11/21/2024 | |
Relative Prices - CSAN3
| Price/Earnings | 9.18 |
| Price/SBV | 1.03 |
| Price/Net Sales | 0.49 |
| Price/CFO | 1.81 |
| Price/FCF | 4.71 |
| Price/Total Assets | 0.14 |
| Price/EBIT | 1.98 |
| Price/Working Capital | 1.41 |
| Price/NCAV | -0.19 |
| EV/EBIT | 7.15 |
| EV/EBITDA | 4.40 |
| EV/Net Sales | 1.78 |
| EV/CFO | 6.52 |
| EV/FCF | 16.99 |
| EV/Total Assets | 0.51 |
| Company Market Cap | R$ 20.53 B |
| Enterprise Value | R$ 74.13 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 11.00 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 4.10% |
| Updated 11/21/2024 | |
Income Statement - CSAN3
| Net Revenue | R$ 41.69 B |
| Gross Result | R$ 12.74 B |
| EBIT | R$ 10.36 B |
| Depreciation and Amortization | - R$ 6.47 B |
| EBITDA | R$ 16.84 B |
| Net Profit | R$ 2.24 B |
| Net Profit/Share | R$ 1.20 |
| Updated 11/13/2024 | |
| Net Revenue | R$ 11.65 B |
| Gross Result | R$ 3.84 B |
| EBIT | R$ 2.92 B |
| Depreciation and Amortization | - R$ 1.18 B |
| EBITDA | R$ 4.10 B |
| Net Profit | R$ 292.88 M |
| Profit/Share | R$ 0.16 |
| Updated 11/13/2024 | |
Price and Volume Behavior - CSAN3
| Lowest Price 52 weeks | R$ 11.00 |
| Highest Price 52 weeks | R$ 18.89 |
| Variation 2024 | -40.75% |
| Variation 1 year | -37.81% |
| Variation 2 years(total) | -31.40% |
| Variation 2 years(yearly) | -17.13% |
| Variation 3 years(total) | -42.22% |
| Variation 3 years(yearly) | -16.69% |
| Variation 4 years(total) | -39.97% |
| Variation 4 years(yearly) | -11.98% |
| Variation 5 years(total) | -16.66% |
| Variation 5 years(yearly) | -3.58% |
| Average Daily Volume (3 months) | R$ 128.86 M |
| Updated 11/21/2024 | |
Returns and Margins - CSAN3
| Return on Initial Tangible Capital | 7.66% |
| Return on Initial Invested Capital | 10.42% |
| Pre-Tax Return on Initial Tangible Capital | 11.60% |
| Pre-Tax Return on Initial Invested Capital | 15.78% |
| Return on Initial Shareholder´s Equity | 12.10% |
| Return on Initial Asset | 1.62% |
| Gross Margin | 30.57% |
| Net Margin | 5.36% |
| EBIT Margin | 24.86% |
| EBITDA Margin | 40.39% |
| Initial Asset Turnover | 0.30 |
| Financial Leverage | 7.27 |
| Liabilities/Net Worth | 6.27 |
| Net Debt/EBITDA | 3.18 |
| Updated 11/13/2024 | |
Balance Sheet - CSAN3
| Cash and Cash Equivalents | R$ 14.63 B |
| Total Assets | R$ 144.83 B |
| Short-Term Debt | R$ 5.47 B |
| Long-Term Debt | R$ 62.75 B |
| Gross Debt | R$ 68.22 B |
| Net Debt | R$ 53.59 B |
| Shareholder´s Equity | R$ 19.92 B |
| Share Book Value | R$ 10.67 |
| Common Shares | 1,866,570,932 |
| Preferred Shares | 0 |
| Total | 1,866,570,932 |
| Common Shares in Treasury | 1,417,546 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,417,546 |
| Common Shares (Except Treasury) | 1,865,153,386 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 1,865,153,386 |
| Updated 11/13/2024 | |
Cash Flow - CSAN3
| Operating Cash Flow | R$ 11.36 B |
| Cash Flow from Investments | - R$ 2.61 B |
| Financing Cash Flow | - R$ 9.30 B |
| Increase (Reduction) in Cash and Equivalents | - R$ 453.81 M |
| Updated 11/13/2024 | |
| Operating Cash Flow | R$ 3.26 B |
| Cash Flow from Investments | - R$ 2.65 B |
| Financing Cash Flow | - R$ 3.19 B |
| Increase (Reduction) in Cash and Equivalents | - R$ 2.60 B |
| Updated 11/13/2024 | |
Experimental - CSAN3
| CAPEX 3 months | - R$ 1.96 B |
| Free Cash Flow 3 months | R$ 1.31 B |
| CAPEX 12 months | - R$ 7.00 B |
| Free Cash Flow 12 months | R$ 4.36 B |
| Updated 11/13/2024 | |